Hubungan Kadar Estradiol Serum Dengan Densitas Tulang Pada Wanita Menopause
DAFTAR PUSTAKA
1.
Data dan Informasi Kinerja Pembangunan Republik Indonesia 2004
– 2012. Diakses dari : http://www.bappenas.go.id
2.
MenKes R.I. 2008 Keputusan Menteri Kesehatan Republik
Indonesia nomor 1142/Menkes/SK/XII/2008 tentang Pedoman
Pengendalian Osteoporosis
3.
Klein NA, Soules MR. Endocrine changes of the menopause. Clin
Obstet Gynecol 2004;41:912-20,
4.
Nochtigall LE. The symptoms of perimenopause. Clin Obstet
Gynecol 2004;41:921-27,
5.
Speroff L, Osteoporosis and Menopause and Postmenopausal
Hormon Therapy. In Clinical Gynecologic Endocrinology and
Infertility, 8th.ed, Williams & Wilkins, USA, 2011, 583-650 Speroff L,
Osteoporosis and Menopause and Postmenopausal Hormon
Therapy. In Clinical Gynecologic Endocrinology and Infertility,
8th.ed, Williams & Wilkins, USA, 2011, 583-650
6.
Lukanova A, Lundin E, Zelenuich-Jacquotte A, Muti P, Murel A,
Rinaldi S, et al. 2004 Body mass index, circulating levels of sexsteroid hormones, IGF-I and IGF-binding protein-3: a crosssectional
study
in
healthy
women,
European
Journal
of
Endocrinology; 150: 161-171
7.
Baziad A. 2003 Endokrinologi Ginekologi. Edisi Kedua. Media
Aesculapius. Fakultas Kedokteran Universitas Indonesia. 82-84
65
Universitas Sumatera Utara
8.
Hurd WW. Menopause In : Berek JS (ed) Novak‟s Gynekology.
Twelfth Edition The william and Wilkins Company,Baltimore, 2010;
29: 981-1011
9.
World Health Organization, 1996. Assesment of Fracture Risk and
Its Aplication to Skreening for Post Menopausal Osteoporosis.
WHO Technical Reports Series;834
10.
Gallagher, J.C, Fowler S.E, Detter J.R dan Sherman S.S. 2001.
Combination Treatment with Estrogen and Calcitrol in The
Prevention of Age-Related Bone Loss. J Clin Endocrinol Metab; 86 :
3618-28
11.
Jasienka et al. CYP17 Genotypes Differ in Salivary 17-b Estradiol
Levels: A Study Based on Hormonal Profiles from Entire Menstrual
Cycles. Cancer Epidemiol Biomarkers.2006; 10 (11): 2132-2135
12.
Abernethy K, Hillard A, McFall P, et al. Menopause: lifEstyle and
therapeutic approaches. Royal College of Nursing, 21
13.
Sutanto L dan Sutando D.B. Menopause wanita dan Gizi, FK UI,
Jakarta 2005
14.
Shimp, LA dan Smith, M.A. Twenty Common Problems in Womans
Health Care International Edision 2000. Singapore : McGrown-Hill
Book Co
15.
Johnston JM, Colvin A, Johnson BD, et al. Comparison of SWAN
and WISE Menopausal Status Classification Algorithms. Journal of
Women‟s Health. Volume 15, Number 10, 2006
66
Universitas Sumatera Utara
16.
Lock M, Kaufert P. MEnopAuSe, Local Biologies, and Cultures of
Aging. American Journal of Human Biology. Vol 13:494-504, 2001
17.
Palmer JR, Rosenberg L, Wise LA, et al. Onset of Natural
Menopause in African American Women. American Journal of
Public Health. February 2013, vol 93 No.2.
18.
Anonym. Overview of Menopause. Chapter 1. Available from:
http://www.menopause.org/docs/2012/cg_a.pdf?sfvrsn=2.
Acces
August 22,2014
19.
Isabela L. 2011. Tingkat Pengetahuan Wanita Pada Masa
Klimakterium Tentang Menopause Di Kelurahan Simpang Selayang
Medan.
Available
from:http://repository.usu.ac.id/handle/123456789/22413
20.
Ballard KD, Kuh DJ, Wadsworth MEJ. The Role of the Menopause
in Women‟s Experiences of the „Change of Life‟. Sociology of
Health and Illness Vol. 23 No.4. 2001, p397-424.
21.
Iswayuni N. 2011. Pemberian Ekstrak Plasenta Meningkatkan
Kadar Estradiol dan FSH Serta Mengurangi Gejala Menopause.
Available from: http://www.pps.unud.ac.id/thesis/pdf_thesis/unud234-1769780408-babii.pdf. diakses tanggal 22 Agustus,2014
22.
Baziad A. Menopause. Endokrinologi Ginekologi edisi ketiga.
Jakarta. Media Aesculapius. 2008;60-61
23.
Kawiyana, I.K.S., 2009, Osteoporosis-Patogenesis, Diagnosis, dan
Penanganan Terkini. J Peny Dalam.10;2: 157-69.
67
Universitas Sumatera Utara
24.
Manolagas SC, Jilka RL., 1995, Bone marrow cytokines and bone
remodeling
emerging
insights
into
the
pathophysiology
of
osteoporosis. N Eng J Med ;332(5):305-10
25.
Ross PD. Osteoporosis frequency, consequences and risk factor:
Arch. Internal Med; 1996; 156(13):1399-14
26.
Rahman IA. Osteoporosis Primer. In : Suherman SK dan Tobing
SDAL (Eds). Osteoporosis, edisi 1. CV Infomedika,2006:1-16.
27.
Percival, M. Bone health and osteoporosis. Advanced Nutrition
Publications. 1999; Vol.5 no.4:1-6
28.
Nackhbandi, I., Van Ser Merwe, S.W., 2009. Current understanding
of osteoporosis associated with liver disease. Gastroenterology and
Hepatology, vol 6:660-70
29.
Ormarsdottir, S.2001. Osteoporosis in Chronic Liver Disease. Tryck
and Medier, Uppsala University, 7-47
30.
Rouillard, S and Lane, N.E. 2001. Hepatic osteodistrophy.
American Association for study of liver disease. 301-7
31.
Setiyohadi, B., 2006. Osteoporosis dalam Sudoyo. A.W., Setyohadi,
B., Alwi, I., Simadibrata, M., Setiati, S, (eds) Buku Ajar Ilmu
Penyakit Dalam. Edisi IV. Pusat Penerbitan Departemen Ilmu
Penyakit Dalam FKUI. Jakarta; 1269-83
32.
Kawiyana, I.K.S., 2009, Crosslink Telopeptida C-Terminal (CTx)
sebagai petanda aktivitas Sel Osteoklas pada Osteoporosis Paska
Menopause Defisiensi Estrogen. J Peny Dalam.10;2: 79-84.
68
Universitas Sumatera Utara
33.
Tesar, R., Caudill, J., Colquhon, A., Krueger, D., 2008. Bone
densitometry
curse.
The
international
society
for
clinical
densitometry. Version 8.
34.
Lindsay, R. Pathogenesis of Postmenopausal osteoporosis, Bailirre
Clinical Rhemathology.1993; Vol. 7, Issue 3: 499-513
35.
Turner, L., Freemen, J. Osteoporosis: It’s more than calcium.
Journal of health Promotich. 2004; Vol. 2, Issue 3:12-29
36.
Uretmena, S., Golb, M., Cimriuc and Irmakd, E. Effect of chronic
liver
disease
on
BMD
and
bone
metabolism
markers
in
postmenopause woman, European Journal of Obstetrics and
gynecology and reproductive biology.2005; Vol. 122, Issue1:67-71
37.
Emma S. W., 2000, Tetap Bugar di Usia Lanjut. Trubus Agriwidya.
38.
Suzuki T. 2001. Risk Faktor for Osteoporosis in Asia. J Bone Miner
metab.19: 133-141.
39.
Butros Dde A N Nj, Nahas EA, Cangusu LM, Barral AB, Kawakami
MS, Risk Factors for Osteoporosis in postmenopousal women from
southeast brazillian. 2011. Juni; 33(6): 295-302
40.
Johnell. Advances in osteoporosis: better identification of
risk
factors can reduce morbidity and mortality: J Internal Med 1996.
239(4): 299-304
41.
Compston,
J.E.
1986.
Hepatic
osteodistrophy:
vitamin
D
metabolism in patients with liver disease. Gut vol 27:1073-90
42.
Mundi, J.S., Cabalero, F.J.C., Abadia, H.C., and Ibnes, J.J.M..
Bone massa density and serum levels of soluble TNF, estradiol and
69
Universitas Sumatera Utara
osteoprotegerin in postmenopause women. Journal of clinical
endocrinology and metabolism. 2009; Vol. 94 No. 12:4844-50
43.
Johnell. Advances in osteoporosis: better identification of
risk
factors can reduce morbidity and mortality: J Internal Med 1996.
239(4): 299-304
44.
Mac Donald HM NS, Golden MH, Campbell MK, Reid DM,
Nutritional associations with bone loss during the menopousal
transitition : evidence of a beneficial effect of calcium, alcohol, and
fruit, and vegetable nutrients and of a detrimental effect of fatty
acids 2004:155-65
45.
Lerner UH. Bone remodeling in post-menopausal osteoporosis. J
Den Res 85,2006:584-595.
46.
Rizzoli R. Pathophysiology of bone loss. 17th IOF Advanced
Training Course on Osteoporosis. Lyon, France, January 29-31,
2008.
47.
Heinemann L,Potthoff.P, Schneider.H. International versus of The
Menopause Rating Scale: A Methodological review. Health and
Quality of Life Outcome 2003; 1:28
48.
Kaunitz AM. Oral contraceptive use in menopause. Am J Obstet
Gynecol 2001; 185: S32-7, Klein NA, Soules MR. Endocrine
changes of the menopause. Clin Obstet Gynecol 2004;41:912-20
49.
Aprilia,
Dina
Ariestine.
2010.
Terapi
Suluh
Hormon Pada
Osteoporosis. Universitas Sumatera Utara
70
Universitas Sumatera Utara
50.
Goodman N, Cobin R, Ginzburg S, Katz I, Woode D, 2011.
American
Association
of
Clinical
Endocrinologists
Medical
Guidelines for Clinical Practice for the Diagnosis and Treatment of
Menopause. AACE Guidelines, 2-17, Sherwood, L. 2001. Human
Physiology: From cells to System). 2th. ed. Division of International
Thomson Publishing Inc. 725-728.
51.
Wardhana, Wisnu. 2012. Faktor – Faktor Risiko Osteoporosis Pada
Pasien Dengan Usia Di Atas 50 Tahun. Universitas Diponegoro
52.
Bambang Setiyohadi. 2001. Osteoporosis dan Penatalaksanaanya.
Naskah yang dibacakan pada pertemuan Osteoporosis pada
Lansia.Denpasar 24 Agustus.
53.
Seeman E. 2003. Physiology of Aging. Invite review : Pathogenesis
of Osteoporosis. J Appl Physiol : 95; 2124-51.
54.
Jordan K. M dan Cooper C. 2008. Epidemiology od Osteoporosis.
Best Practice and Reasearch Clinical Rheumatology; 16(5) : 795806.
55.
Malavolta, N Zanardi M, Veronesi M, Ripamonti C dan Gnudi S.
1999.
Calcitrol and Alendronate
Combination Treatment
in
Menopausal Women with Low Bone Mass. Int.J. Tissue React;
20(12): 51-9.
56.
Tamura T, et al. 1993. Soluble Interleukin-^ Receptor Triggers
Osteoklast Formation by Interleukin ^. Proc. Natl. Acad. Sci; 90;
11924-8.
71
Universitas Sumatera Utara
1.
Data dan Informasi Kinerja Pembangunan Republik Indonesia 2004
– 2012. Diakses dari : http://www.bappenas.go.id
2.
MenKes R.I. 2008 Keputusan Menteri Kesehatan Republik
Indonesia nomor 1142/Menkes/SK/XII/2008 tentang Pedoman
Pengendalian Osteoporosis
3.
Klein NA, Soules MR. Endocrine changes of the menopause. Clin
Obstet Gynecol 2004;41:912-20,
4.
Nochtigall LE. The symptoms of perimenopause. Clin Obstet
Gynecol 2004;41:921-27,
5.
Speroff L, Osteoporosis and Menopause and Postmenopausal
Hormon Therapy. In Clinical Gynecologic Endocrinology and
Infertility, 8th.ed, Williams & Wilkins, USA, 2011, 583-650 Speroff L,
Osteoporosis and Menopause and Postmenopausal Hormon
Therapy. In Clinical Gynecologic Endocrinology and Infertility,
8th.ed, Williams & Wilkins, USA, 2011, 583-650
6.
Lukanova A, Lundin E, Zelenuich-Jacquotte A, Muti P, Murel A,
Rinaldi S, et al. 2004 Body mass index, circulating levels of sexsteroid hormones, IGF-I and IGF-binding protein-3: a crosssectional
study
in
healthy
women,
European
Journal
of
Endocrinology; 150: 161-171
7.
Baziad A. 2003 Endokrinologi Ginekologi. Edisi Kedua. Media
Aesculapius. Fakultas Kedokteran Universitas Indonesia. 82-84
65
Universitas Sumatera Utara
8.
Hurd WW. Menopause In : Berek JS (ed) Novak‟s Gynekology.
Twelfth Edition The william and Wilkins Company,Baltimore, 2010;
29: 981-1011
9.
World Health Organization, 1996. Assesment of Fracture Risk and
Its Aplication to Skreening for Post Menopausal Osteoporosis.
WHO Technical Reports Series;834
10.
Gallagher, J.C, Fowler S.E, Detter J.R dan Sherman S.S. 2001.
Combination Treatment with Estrogen and Calcitrol in The
Prevention of Age-Related Bone Loss. J Clin Endocrinol Metab; 86 :
3618-28
11.
Jasienka et al. CYP17 Genotypes Differ in Salivary 17-b Estradiol
Levels: A Study Based on Hormonal Profiles from Entire Menstrual
Cycles. Cancer Epidemiol Biomarkers.2006; 10 (11): 2132-2135
12.
Abernethy K, Hillard A, McFall P, et al. Menopause: lifEstyle and
therapeutic approaches. Royal College of Nursing, 21
13.
Sutanto L dan Sutando D.B. Menopause wanita dan Gizi, FK UI,
Jakarta 2005
14.
Shimp, LA dan Smith, M.A. Twenty Common Problems in Womans
Health Care International Edision 2000. Singapore : McGrown-Hill
Book Co
15.
Johnston JM, Colvin A, Johnson BD, et al. Comparison of SWAN
and WISE Menopausal Status Classification Algorithms. Journal of
Women‟s Health. Volume 15, Number 10, 2006
66
Universitas Sumatera Utara
16.
Lock M, Kaufert P. MEnopAuSe, Local Biologies, and Cultures of
Aging. American Journal of Human Biology. Vol 13:494-504, 2001
17.
Palmer JR, Rosenberg L, Wise LA, et al. Onset of Natural
Menopause in African American Women. American Journal of
Public Health. February 2013, vol 93 No.2.
18.
Anonym. Overview of Menopause. Chapter 1. Available from:
http://www.menopause.org/docs/2012/cg_a.pdf?sfvrsn=2.
Acces
August 22,2014
19.
Isabela L. 2011. Tingkat Pengetahuan Wanita Pada Masa
Klimakterium Tentang Menopause Di Kelurahan Simpang Selayang
Medan.
Available
from:http://repository.usu.ac.id/handle/123456789/22413
20.
Ballard KD, Kuh DJ, Wadsworth MEJ. The Role of the Menopause
in Women‟s Experiences of the „Change of Life‟. Sociology of
Health and Illness Vol. 23 No.4. 2001, p397-424.
21.
Iswayuni N. 2011. Pemberian Ekstrak Plasenta Meningkatkan
Kadar Estradiol dan FSH Serta Mengurangi Gejala Menopause.
Available from: http://www.pps.unud.ac.id/thesis/pdf_thesis/unud234-1769780408-babii.pdf. diakses tanggal 22 Agustus,2014
22.
Baziad A. Menopause. Endokrinologi Ginekologi edisi ketiga.
Jakarta. Media Aesculapius. 2008;60-61
23.
Kawiyana, I.K.S., 2009, Osteoporosis-Patogenesis, Diagnosis, dan
Penanganan Terkini. J Peny Dalam.10;2: 157-69.
67
Universitas Sumatera Utara
24.
Manolagas SC, Jilka RL., 1995, Bone marrow cytokines and bone
remodeling
emerging
insights
into
the
pathophysiology
of
osteoporosis. N Eng J Med ;332(5):305-10
25.
Ross PD. Osteoporosis frequency, consequences and risk factor:
Arch. Internal Med; 1996; 156(13):1399-14
26.
Rahman IA. Osteoporosis Primer. In : Suherman SK dan Tobing
SDAL (Eds). Osteoporosis, edisi 1. CV Infomedika,2006:1-16.
27.
Percival, M. Bone health and osteoporosis. Advanced Nutrition
Publications. 1999; Vol.5 no.4:1-6
28.
Nackhbandi, I., Van Ser Merwe, S.W., 2009. Current understanding
of osteoporosis associated with liver disease. Gastroenterology and
Hepatology, vol 6:660-70
29.
Ormarsdottir, S.2001. Osteoporosis in Chronic Liver Disease. Tryck
and Medier, Uppsala University, 7-47
30.
Rouillard, S and Lane, N.E. 2001. Hepatic osteodistrophy.
American Association for study of liver disease. 301-7
31.
Setiyohadi, B., 2006. Osteoporosis dalam Sudoyo. A.W., Setyohadi,
B., Alwi, I., Simadibrata, M., Setiati, S, (eds) Buku Ajar Ilmu
Penyakit Dalam. Edisi IV. Pusat Penerbitan Departemen Ilmu
Penyakit Dalam FKUI. Jakarta; 1269-83
32.
Kawiyana, I.K.S., 2009, Crosslink Telopeptida C-Terminal (CTx)
sebagai petanda aktivitas Sel Osteoklas pada Osteoporosis Paska
Menopause Defisiensi Estrogen. J Peny Dalam.10;2: 79-84.
68
Universitas Sumatera Utara
33.
Tesar, R., Caudill, J., Colquhon, A., Krueger, D., 2008. Bone
densitometry
curse.
The
international
society
for
clinical
densitometry. Version 8.
34.
Lindsay, R. Pathogenesis of Postmenopausal osteoporosis, Bailirre
Clinical Rhemathology.1993; Vol. 7, Issue 3: 499-513
35.
Turner, L., Freemen, J. Osteoporosis: It’s more than calcium.
Journal of health Promotich. 2004; Vol. 2, Issue 3:12-29
36.
Uretmena, S., Golb, M., Cimriuc and Irmakd, E. Effect of chronic
liver
disease
on
BMD
and
bone
metabolism
markers
in
postmenopause woman, European Journal of Obstetrics and
gynecology and reproductive biology.2005; Vol. 122, Issue1:67-71
37.
Emma S. W., 2000, Tetap Bugar di Usia Lanjut. Trubus Agriwidya.
38.
Suzuki T. 2001. Risk Faktor for Osteoporosis in Asia. J Bone Miner
metab.19: 133-141.
39.
Butros Dde A N Nj, Nahas EA, Cangusu LM, Barral AB, Kawakami
MS, Risk Factors for Osteoporosis in postmenopousal women from
southeast brazillian. 2011. Juni; 33(6): 295-302
40.
Johnell. Advances in osteoporosis: better identification of
risk
factors can reduce morbidity and mortality: J Internal Med 1996.
239(4): 299-304
41.
Compston,
J.E.
1986.
Hepatic
osteodistrophy:
vitamin
D
metabolism in patients with liver disease. Gut vol 27:1073-90
42.
Mundi, J.S., Cabalero, F.J.C., Abadia, H.C., and Ibnes, J.J.M..
Bone massa density and serum levels of soluble TNF, estradiol and
69
Universitas Sumatera Utara
osteoprotegerin in postmenopause women. Journal of clinical
endocrinology and metabolism. 2009; Vol. 94 No. 12:4844-50
43.
Johnell. Advances in osteoporosis: better identification of
risk
factors can reduce morbidity and mortality: J Internal Med 1996.
239(4): 299-304
44.
Mac Donald HM NS, Golden MH, Campbell MK, Reid DM,
Nutritional associations with bone loss during the menopousal
transitition : evidence of a beneficial effect of calcium, alcohol, and
fruit, and vegetable nutrients and of a detrimental effect of fatty
acids 2004:155-65
45.
Lerner UH. Bone remodeling in post-menopausal osteoporosis. J
Den Res 85,2006:584-595.
46.
Rizzoli R. Pathophysiology of bone loss. 17th IOF Advanced
Training Course on Osteoporosis. Lyon, France, January 29-31,
2008.
47.
Heinemann L,Potthoff.P, Schneider.H. International versus of The
Menopause Rating Scale: A Methodological review. Health and
Quality of Life Outcome 2003; 1:28
48.
Kaunitz AM. Oral contraceptive use in menopause. Am J Obstet
Gynecol 2001; 185: S32-7, Klein NA, Soules MR. Endocrine
changes of the menopause. Clin Obstet Gynecol 2004;41:912-20
49.
Aprilia,
Dina
Ariestine.
2010.
Terapi
Suluh
Hormon Pada
Osteoporosis. Universitas Sumatera Utara
70
Universitas Sumatera Utara
50.
Goodman N, Cobin R, Ginzburg S, Katz I, Woode D, 2011.
American
Association
of
Clinical
Endocrinologists
Medical
Guidelines for Clinical Practice for the Diagnosis and Treatment of
Menopause. AACE Guidelines, 2-17, Sherwood, L. 2001. Human
Physiology: From cells to System). 2th. ed. Division of International
Thomson Publishing Inc. 725-728.
51.
Wardhana, Wisnu. 2012. Faktor – Faktor Risiko Osteoporosis Pada
Pasien Dengan Usia Di Atas 50 Tahun. Universitas Diponegoro
52.
Bambang Setiyohadi. 2001. Osteoporosis dan Penatalaksanaanya.
Naskah yang dibacakan pada pertemuan Osteoporosis pada
Lansia.Denpasar 24 Agustus.
53.
Seeman E. 2003. Physiology of Aging. Invite review : Pathogenesis
of Osteoporosis. J Appl Physiol : 95; 2124-51.
54.
Jordan K. M dan Cooper C. 2008. Epidemiology od Osteoporosis.
Best Practice and Reasearch Clinical Rheumatology; 16(5) : 795806.
55.
Malavolta, N Zanardi M, Veronesi M, Ripamonti C dan Gnudi S.
1999.
Calcitrol and Alendronate
Combination Treatment
in
Menopausal Women with Low Bone Mass. Int.J. Tissue React;
20(12): 51-9.
56.
Tamura T, et al. 1993. Soluble Interleukin-^ Receptor Triggers
Osteoklast Formation by Interleukin ^. Proc. Natl. Acad. Sci; 90;
11924-8.
71
Universitas Sumatera Utara